ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Neuromusculoskeletal Medicine OMM

Top Neuromusculoskeletal Medicine OMM Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WESNER MOISE M.D.

Neuromusculoskeletal Medicine OMM

14,672

$849K

547
503 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 28%

$58
Average prescription price

Avg: $111

LAURA SCHOENBERG M.D.

Neuromusculoskeletal Medicine OMM

3,397

$1.23M

263
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 28%

$361
Average prescription price

Avg: $111

LEWIS BASS MD

Neuromusculoskeletal Medicine OMM

3,144

$286K

192
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 28%

$91
Average prescription price

Avg: $111

MEHRI SONGHORIAN MD

Neuromusculoskeletal Medicine OMM

2,246

$195K

190
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $111

JAMES LIGUORI DO

Neuromusculoskeletal Medicine OMM

1,630

$145K

222
124 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $111

PHILIP RAGONE MD

Neuromusculoskeletal Medicine OMM

1,479

$245K

260
243 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 28%

$166
Average prescription price

Avg: $111

BERNARD SAVELLA M.D.

Neuromusculoskeletal Medicine OMM

1,469

$128K

204
159 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $111

NORA CHAN MD

Neuromusculoskeletal Medicine OMM

1,235

$206K

153
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 28%

$167
Average prescription price

Avg: $111

RICHARD NOVITCH M.D.

Neuromusculoskeletal Medicine OMM

1,176

$60.8K

147
135 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $111

KERIN HAUSKNECHT MD

Neuromusculoskeletal Medicine OMM

1,063

$83K

104
43 are 65+

36%
patients receiving schedule two controlled substances

Avg: 9%

27%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $111

PASQUALE FONZETTI MD

Neuromusculoskeletal Medicine OMM

854

$118K

111
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 28%

$139
Average prescription price

Avg: $111

BENTO MASCARENHAS M.D.

Neuromusculoskeletal Medicine OMM

824

$221K

175
154 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 28%

$268
Average prescription price

Avg: $111

STEVEN SCHWARTZ M.D.

Neuromusculoskeletal Medicine OMM

677

$117K

71
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$173
Average prescription price

Avg: $111

KIM SING LO D.O.

Neuromusculoskeletal Medicine OMM

628

$106K

228
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

76%
prescriptions for brand name drugs

Avg: 28%

$169
Average prescription price

Avg: $111

ANGELA STROE D.O.

Neuromusculoskeletal Medicine OMM

594

$21.5K

155
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 28%

$36
Average prescription price

Avg: $111

ELLEN GITLER M.D

Neuromusculoskeletal Medicine OMM

577

$24.1K

191
180 are 65+

45%
patients receiving schedule two controlled substances

Avg: 9%

30%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 28%

$42
Average prescription price

Avg: $111

CHARLENE SCHEIM DO

Neuromusculoskeletal Medicine OMM

546

$41.4K

40
12 are 65+

50%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $111

DAVID GENTILE DO

Neuromusculoskeletal Medicine OMM

306

$22.3K

80
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 28%

$73
Average prescription price

Avg: $111

JERRY KAPLAN M.D.

Neuromusculoskeletal Medicine OMM

244

$12.3K

57
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $111

GEORGE UNIS M.D.

Neuromusculoskeletal Medicine OMM

213

$3,427

93
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 28%

$16
Average prescription price

Avg: $111

IGOR BENEDITSKIY MD, DO

Neuromusculoskeletal Medicine OMM

184

$8,279

91
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$45
Average prescription price

Avg: $111

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank